相关实验视频

Updated: Mar 17, 2026

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

在ANCA相关的血管炎中针对抗CD19的CAR T细胞疗法

Luisa Schneider¹, Ann-Christin Pecher¹, Luca Hensen¹

¹Department for Internal Medicine II (Hematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tübingen, Tübingen, Germany.

Rheumatology (Oxford, England)

|March 16, 2026

概括

抗CD19CAR T细胞疗法提供了一种有前途的新疗法,用于耐火性多炎 (GPA) 颗粒瘤. 本案例研究显示,在这种创新疗法后,一名患者实现了完全缓解.

科学领域:

免疫治疗是一种免疫疗法.
自免疫性疾病自免疫性疾病
血液学血液学血液学

背景情况:

带有多叶膜炎 (GPA) 的粒状瘤炎是一种罕见的自身免疫性血管炎.
复发性和耐火性GPA带来了重大的治疗挑战.
标准的免疫抑制疗法在严重病例中通常具有有限的疗效.

研究的目的:

评估CD19向的化学抗原受体 (CAR) T细胞治疗的安全性和有效性.
介绍一个病例研究,一个患有复发性,耐火性GPA的病人用CAR T细胞治疗.
探索一种针对严重自身免疫性血管炎的新型治疗方法.

主要方法:

一名69岁的男性患有耐火性GPA,接受了针对CD19的CAR T细胞治疗.
治疗包括使用弗鲁达拉和环胺的调节方案.
患者监测包括临床评估 (BVAS),成像 (CT),炎症标志物 (CRP) 和免疫分析.

主要成果:

患者经历了快速的临床,放射和实验室改善.
卡尔-T细胞治疗耐受性良好,没有细胞因子释放综合征或神经毒性.
在治疗后12个月内实现并维持完全缓解,没有进一步的药物治疗.

结论:

针对CD19的CAR T细胞疗法是复发/耐药GPA的安全有效选择.
这种疗法显示出有可能显著改变疾病管理并改善患者的治疗结果.
卡尔-T细胞疗法代表了治疗严重自身免疫性疾病的范式转变.

关键词:

CD19 卡尔-T 细胞在这里,我们还可以看到Anca Anca.自身免疫性疾病自身免疫性疾病血管炎是一种血管炎.

更多相关视频

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.